![](https://static.scientificamerican.com/sciam/cache/file/15F02C41-6301-4032-8043B05E5C8816C6_agenda.jpg?w=275&h=154&fit=crop)
A Simple Solution Would Make COVID Antivirals More Accessible, Pharmacists Say
The Biden administration’s Test to Treat program aims to make the treatments available at pharmacies, yet it requires a medical provider to prescribe the drugs
The Biden administration’s Test to Treat program aims to make the treatments available at pharmacies, yet it requires a medical provider to prescribe the drugs
Researchers are trying to establish whether existing COVID-19 vaccines and treatments can prevent lasting symptoms
Instructing our cells to make specific proteins could control influenza, autoimmune diseases, even cancer
Gum carrying a protein produced by genetically modified lettuce traps SARS-CoV-2
Different methods of drug delivery give us more tools to fight disease
MDMA, known as Ecstasy in the clubs, gained high marks in a clinical trial for PTSD
But shortages mean that new antivirals and other drugs may be hard to come by
SARS-CoV-2 adds impetus to the race for broad-spectrum countermeasures against future global infectious scourges
For decades, assumptions about weight have clouded our view of health
A drug made by Merck and Ridgeback Biotherapeutics—which an FDA panel recently greenlit—and one made by Pfizer work in different ways, but both prevent the virus from replicating...
After long delay, U.S. President Joe Biden picks Robert Califf to once again head the U.S. Food and Drug Administration
Researchers are still puzzling over what this drug does at the molecular level to help COVID patients
Over-the-counter analgesics can be quite effective, but high doses have downsides
The Merck pill, which could become the first oral antiviral COVID treatment, forces the coronavirus SARS-CoV-2 to mutate itself to death
There are three legal pathways to deregulating the drug under the Controlled Substances Act
The organizations touting unproved protocols for the antiparasitic drug may be harming vaccination efforts
New research has created microscopic antibiotic factories in droplets that measure a trillionth of liter in volume.
The military is creating “smart” E. coli to combat a variety of disorders faced by warfighters
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account